PT - JOURNAL ARTICLE AU - Spencer, EA AU - Ford, GA AU - Chan, MS AU - Perera, R AU - Heneghan, CJ TI - Biomarkers in the prediction of multimorbidity: scoping review AID - 10.1101/2020.11.25.20214999 DP - 2020 Jan 01 TA - medRxiv PG - 2020.11.25.20214999 4099 - http://medrxiv.org/content/early/2020/11/27/2020.11.25.20214999.short 4100 - http://medrxiv.org/content/early/2020/11/27/2020.11.25.20214999.full AB - Background Multimorbidity presents an increasing challenge in the global ageing population. Predicting its development is necessary to help design and deliver effective healthcare.Objective This scoping review aimed to collate and present the body of published evidence on biomarkers and multimorbidity, identifying what work has been done and what gaps remain.Methods We searched the electronic databases MEDLINE, Register of Controlled Trials (Cochrane CENTRAL), CINAHL, PsycINFO, EMBASE, Scopus, Web of Science and TRIP database up until 11 August 2020 and hand-searched the reference lists of included articles.Results We found 34 relevant studies including 12 reporting prospective data and 22 reporting cross-sectional data. These encompassed 14 studies on serum biomarkers, 2 on molecular biomarkers, 7 on physiological biomarkers, 8 on body size biomarkers and 3 on brain function biomarkers. Most studies were undertaken in European or North American populations. There was a broadly consistent finding that obesity was associated with increased multimorbidity. Other results were more varied, reflecting the diverse range of biomarkers investigated, and lack of standardisation of multimorbidity outcome definitions.Longitudinal studies have been set up that are maturing and further evidence can be expected over time.Conclusion There has been limited research on biomarkers to predict the development of multimorbidity, with minimal investigation of putative biomarkers identified in basic research. High quality research studies in this area are needed to progress the development of targeted interventions to prevent or delay the onset of multimorbidity.Competing Interest StatementCH receives funding support from the NIHR (National Institute for Health Research) School for Primary Care Research Evidence Synthesis Working group (NIHR SPCR ESWG project 390) and the NIHR Oxford Biomedical Research Centre. He is an NIHR senior investigator, editor in chief of BMJ Evidence-Based Medicine, and an NHS urgent care GP and has received payments for his media work (full declaration at www.phc.ox.ac.uk/team/carl-heneghan). GAF has received personal remuneration from Amgen, Daiichi Sankyo, Medtronic, Stryker for educational and consulting activities unrelated to this work. RP acknowledges part-funding from the National Institute for Health Research (NIHR Programme Grant for Applied Research), the NIHR Oxford Biomedical Research Centre, the NIHR Oxford and Thames Valley Applied Research Collaborative (ARC), NIHR Oxford Medtech and In-Vitro Diagnostics Co-operative and the Oxford Martin School. EAS and MSC declare no conflicts of interest.Funding StatementEAS is supported by funding from UK Spine Knowledge Exchange Fund. No additional external funding was received for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis is a review of publicly available data published in the scientific literature.